Editorial: The human microbiome - A therapeutic target for prevention and treatment of chronic disease

Current Pharmaceutical Design

Volumn 15, Issue 13, 2009, Pages 1401-1402

  Tuohy, Kieran ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; IMMUNOGLOBULIN A; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; XENOBIOTIC AGENT;

CANCER RISK; COLON CANCER; COLON FLORA; DIETARY INTAKE; EDITORIAL; ENERGY METABOLISM; ENTERITIS; ENVIRONMENTAL FACTOR; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INTESTINE FLORA; LIPID STORAGE; METABOLIC PARAMETERS; METABOLOMICS; METAGENOMICS; MICROBIAL ACTIVITY; MICROBIOLOGICAL EXAMINATION; MICROBIOME; NATURAL KILLER CELL; OBESITY; PATIENT CARE; PEPTIDE SYNTHESIS; PHAGOCYTOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN DIFFERENCE; SYMBIOSIS; WEIGHT REDUCTION; CHRONIC DISEASE; DIET THERAPY; GASTROINTESTINAL TRACT; METHODOLOGY; MICROBIOLOGY;

CHRONIC DISEASE; DIET THERAPY; GASTROINTESTINAL TRACT; HUMANS; MICROBIOME;

EID: 67650635382     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209788168137     Document Type: Editorial

References (8)

1. Saulnier DM, Kolida S, Gibson GR. Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des 2009; 15(13): 1403-1414.
2. Tuohy KM, Gougoulias C, Shen Q, Walton G, Fava F, Ramnani P. Studying the human gut microbiota in the transomics era- focus on metagenomics and metabonomics. Curr Pharm Des 2009; 15(13): 1415-1427.
3. Lomax AR, Calder PC. Probiotics, immune function, infection and inflammation: A review of the evidence from studies conducted in humans. Curr Pharm Des 2009; 15(13): 1428-1518.
4. Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des 2009; 15(13): 1519-1523.
5. Rowland IR. The role of the gastrointestinal microflora in colorectal cancer. Curr Pharm Des 2009; 15(13): 1524-1527.
6. Macfarlane GT, Blaekett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15(13): 1528-1536.
7. Kinross J, von Roon AC, Penney N, Holmes E, Silk D, Nicholson JK, Darzi A. The gut microbiota as a target for improved surgical outcome and improved patient care. Curr Pharm Des 2009; 15(13): 1537-1545.
8. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15(13): 1546-1558.